While acute TLR4 activity is known to drive pro-inflammatory cytokine production, evidence is emerging that prolonged TLR4 signaling can contribute to a more immunosuppressive response, leading to immune escape by cancer cells (16,51–52). The gene discussed is TLR4; the disease is cancer.